Small Pharmaceuticals
Market Cap
₹17,436 ₹17,436 Cr.
P/E
23.72
PEG
3.12
PEG = P/E ÷ 5yr forward EPS CAGR
5yr forward EPS CAGR thesis · Base case

Prevenar 20's vaccine ramp is the primary growth driver, contributing 45% of incremental revenue by FY31 amid a deliberate shift toward vaccines and specialty.

The bull case triggers on national adult immunization adoption and Prevenar 20 dominance, while the bear case hinges on NLEM expansion and Eliquis generic erosion.

  • Pfizer
  • Eris Lifesciences
  • Alembic Pharma
  • TJI Pharma

FAQs on Pfizer Ltd. Shareprice

Pfizer has given lower returns compared to its competitors.
Pfizer has grown at ~9.63% over the last 9yrs while peers have grown at a median rate of 10.14%

Pfizer is not expensive.
Latest PE of Pfizer is 23.99, while 3 year average PE is 33.0.
Also latest EV/EBITDA of Pfizer is 15.43 while 3yr average is 24.78.

Growth Table

  • Pfizer Ltd.
  • Eris Lifesciences
  • Alembic Pharma

Balance Sheet

  • Pfizer Ltd.
  • Eris Lifesciences
  • Alembic Pharma

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Pfizer Ltd.
  • Eris Lifesciences
  • Alembic Pharma

Cash Flow

  • Pfizer Ltd.
  • Eris Lifesciences
  • Alembic Pharma

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Pfizer Ltd.
  • Eris Lifesciences
  • Alembic Pharma

Quarterly Results

  • Pfizer Ltd.
  • Eris Lifesciences
  • Alembic Pharma

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*

FAQs on Pfizer Ltd. Financials

Balance sheet of Pfizer is strong.
It shouldn't have solvency or liquidity issues.

The net debt of Pfizer is decreasing.
Latest net debt of Pfizer is -₹6,215.3 Crs as of Mar-26.
This is less than Mar-25 when it was -₹5,597.54 Crs.

The profit is oscillating.
The profit of Pfizer is ₹735 Crs for TTM, ₹722 Crs for Mar 2026 and ₹768 Crs for Mar 2025.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Pfizer latest dividend payout ratio is 47.5% and 3yr average dividend payout ratio is 58.29%

Companies resources are allocated to majorly unproductive assets like Cash & Short Term Investments, Capital Work in Progress

Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech